Q&A with Advarra’s Client Services Team Lead Kyle Naylor 

Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never...

Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage 

IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight...

Q&A with Advarra’s Manager of Ongoing Review MaryJo Carter 

MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape...

Ensuring Operational Feasibility in Next-Generation Oncology Trials

Our webinar discusses key near-term trends and regulations and investigate persistent challenges frequently throwing even...

Sponsor’s Guide to IRB Approval (Part V): How to Speed Up IRB Approvals 

Institutional review board (IRB) approval is a critical milestone in clinical research, but it can...

Sponsor’s Guide to IRB Approval (Part IV): Preparing IRB Documents That Prevent Delays

A strong protocol and well-drafted consent form are essential, but they are not enough on...

Q&A with Advarra’s Associate Director of Client Success Evan Sander

Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s about...

Advarra’s Study Design Solution Named “Best Clinical Study Design Solution” in 2026 MedTech Breakthrough Awards Program

Landmark 10th annual awards program, which received over 5,000 entries, recognizes the most innovative digital health and medical technology solutions worldwide  COLUMBIA, Md., – May 7, 2026...

Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent

For sponsors, informed consent is one of the most visible signals of study quality during...

A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct

Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when...

Sponsor’s Guide to IRB Approval (Part II): How to Draft a Clinical Trial Protocol That Stands Up to IRB Scrutiny 

A strong clinical trial protocol does more than describe how a study will run. It...

Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment